KISSEI PHARMACEUTICAL CO LTD has a total of 53 patent applications. It decreased the IP activity by 100.0%. Its first patent ever was published in 2001. It filed its patents most often in Australia, Taiwan and Serbia. Its main competitors in its focus markets pharmaceuticals, organic fine chemistry and biotechnology are RANBAXY LAB LTD, ARDEA BIOSCIENCES INC and SHIZUOKA COFFEIN CO LTD.
# | Industry | |
---|---|---|
#1 | Pharmaceuticals | |
#2 | Organic fine chemistry | |
#3 | Biotechnology |
# | Technology | |
---|---|---|
#1 | Therapeutic chemical compounds | |
#2 | Medical preparations | |
#3 | Heterocyclic compounds | |
#4 | Sugars | |
#5 | Acyclic or carbocyclic compounds | |
#6 | Microorganisms | |
#7 | Peptides | |
#8 | Organic chemistry methods |
# | Name | Total Patents |
---|---|---|
#1 | Fushimi Nobuhiko | 11 |
#2 | Shimizu Kazuo | 11 |
#3 | Isaji Masayuki | 10 |
#4 | Fujikura Hideki | 8 |
#5 | Takigawa Yasushi | 7 |
#6 | Kobayashi Junichi | 6 |
#7 | Ueno Yasunori | 6 |
#8 | Miyagi Takashi | 5 |
#9 | Yonekubo Shigeru | 5 |
#10 | Ohno Kohsuke | 5 |
Publication | Filing date | Title |
---|---|---|
AU2019340173A1 | Imidazopyridinone compound | |
TW202019429A | Hypoxanthine compound | |
TW202003853A | Genetically modified cell and producing method therefor | |
TW201636373A | Fc fusion high affinity IgE receptor alpha chain | |
TW201623241A | Cyclohexylpyridine derivative | |
AU2005219776A1 | Nitrogenous fused-ring derivatives, medicinal compositions containing the derivatives, and use thereof as drugs | |
AU2003254847A1 | Pyrazole derivative, medicinal composition containing the same, medicinal use thereof, and intermediate for production thereof |